APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmacokinetics Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmacokinetics Software Market Analysis and Forecast 2026-2032

Report ID 17421469028 January 2026199 pages

Choose your research edition.

Industry ResearchPharmacokinetics Software Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacokinetics Software Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Pharmacokinetics Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacokinetics Software Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacokinetics Software Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Pharmacokinetics Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmacokinetics Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmacokinetics Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmacokinetics Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmacokinetics Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmacokinetics Software include Certara, Simulations Plus, IntiQuan GmbH, Bayer, Genedata AG, Thermo Scientific, SGS, Pharmaron and Pumas-AI, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmacokinetics Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmacokinetics Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmacokinetics Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmacokinetics Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmacokinetics Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmacokinetics Software revenue, projected growth trends, production technology, application and end-user industry.

Pharmacokinetics Software Segment by Company

Certara

Simulations Plus

IntiQuan GmbH

Bayer

Genedata AG

Thermo Scientific

SGS

Pharmaron

Pumas-AI

PharmoGo

Chuangteng Technology

Medixi Biomedical

Pharmacokinetics Software Segment by Type

Compartmental Model

Non-Compartmental Models

Pharmacokinetics Software Segment by Application

Experimental Design

Clinical Pharmacokinetics

Other

Pharmacokinetics Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacokinetics Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacokinetics Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacokinetics Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmacokinetics Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmacokinetics Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacokinetics Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmacokinetics Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Compartmental Model Major Player Table 3. Non-Compartmental Models Major Player Table 4. Global Pharmacokinetics Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Experimental Design Major Player Table 6. Clinical Pharmacokinetics Major Player Table 7. Other Major Player Table 8. Pharmacokinetics Software Industry Trends Table 9. Pharmacokinetics Software Industry Drivers Table 10. Pharmacokinetics Software Industry Opportunities and Challenges Table 11. Pharmacokinetics Software Industry Restraints Table 12. Global Pharmacokinetics Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Pharmacokinetics Software Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Pharmacokinetics Software Market Share by Region (2021-2026) Table 15. Global Pharmacokinetics Software Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Pharmacokinetics Software Market Share by Region (2027-2032) Table 17. Global Pharmacokinetics Software Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Pharmacokinetics Software Revenue Market Share by Players (2021-2026) Table 19. Global Pharmacokinetics Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pharmacokinetics Software Key Players Headquarters & Area Served Table 21. Global Pharmacokinetics Software Players, Product Type & Application Table 22. Global Pharmacokinetics Software Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Pharmacokinetics Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Pharmacokinetics Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmacokinetics Software Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Pharmacokinetics Software Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Pharmacokinetics Software Revenue Market Share by Type (2021-2026) Table 29. Global Pharmacokinetics Software Revenue Market Share by Type (2027-2032) Table 30. Global Pharmacokinetics Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharmacokinetics Software Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Pharmacokinetics Software Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Pharmacokinetics Software Revenue Market Share by Application (2021-2026) Table 34. Global Pharmacokinetics Software Revenue Market Share by Application (2027-2032) Table 35. Certara Company Information Table 36. Certara Business Overview Table 37. Certara Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Certara Pharmacokinetics Software Product Portfolio Table 39. Certara Recent Development Table 40. Simulations Plus Company Information Table 41. Simulations Plus Business Overview Table 42. Simulations Plus Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Simulations Plus Pharmacokinetics Software Product Portfolio Table 44. Simulations Plus Recent Development Table 45. IntiQuan GmbH Company Information Table 46. IntiQuan GmbH Business Overview Table 47. IntiQuan GmbH Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. IntiQuan GmbH Pharmacokinetics Software Product Portfolio Table 49. IntiQuan GmbH Recent Development Table 50. Bayer Company Information Table 51. Bayer Business Overview Table 52. Bayer Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Bayer Pharmacokinetics Software Product Portfolio Table 54. Bayer Recent Development Table 55. Genedata AG Company Information Table 56. Genedata AG Business Overview Table 57. Genedata AG Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Genedata AG Pharmacokinetics Software Product Portfolio Table 59. Genedata AG Recent Development Table 60. Thermo Scientific Company Information Table 61. Thermo Scientific Business Overview Table 62. Thermo Scientific Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Thermo Scientific Pharmacokinetics Software Product Portfolio Table 64. Thermo Scientific Recent Development Table 65. SGS Company Information Table 66. SGS Business Overview Table 67. SGS Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. SGS Pharmacokinetics Software Product Portfolio Table 69. SGS Recent Development Table 70. Pharmaron Company Information Table 71. Pharmaron Business Overview Table 72. Pharmaron Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Pharmaron Pharmacokinetics Software Product Portfolio Table 74. Pharmaron Recent Development Table 75. Pumas-AI Company Information Table 76. Pumas-AI Business Overview Table 77. Pumas-AI Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Pumas-AI Pharmacokinetics Software Product Portfolio Table 79. Pumas-AI Recent Development Table 80. PharmoGo Company Information Table 81. PharmoGo Business Overview Table 82. PharmoGo Pharmacokinetics Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. PharmoGo Pharmacokinetics Software Product Portfolio Table 84. PharmoGo Recent Development Table 85. Chuangteng Technology Company Information Table 86. Chuangteng Technology Business Overview Table 87. Chuangteng Technology Pharmacokinetics Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Chuangteng Technology Pharmacokinetics Software Product Portfolio Table 89. Chuangteng Technology Recent Development Table 90. Medixi Biomedical Company Information Table 91. Medixi Biomedical Business Overview Table 92. Medixi Biomedical Pharmacokinetics Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Medixi Biomedical Pharmacokinetics Software Product Portfolio Table 94. Medixi Biomedical Recent Development Table 95. North America Pharmacokinetics Software Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Pharmacokinetics Software Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Pharmacokinetics Software Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Pharmacokinetics Software Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Pharmacokinetics Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Pharmacokinetics Software Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Pharmacokinetics Software Revenue by Country (US$ Million) & (2027-2032) Table 102. Europe Pharmacokinetics Software Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Pharmacokinetics Software Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Pharmacokinetics Software Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Pharmacokinetics Software Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Pharmacokinetics Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Pharmacokinetics Software Revenue by Country (2021-2026) & (US$ Million) Table 108. Europe Pharmacokinetics Software Revenue by Country (US$ Million) & (2027-2032) Table 109. China Pharmacokinetics Software Revenue by Type (2021-2026) & (US$ Million) Table 110. China Pharmacokinetics Software Revenue by Type (2027-2032) & (US$ Million) Table 111. China Pharmacokinetics Software Revenue by Application (2021-2026) & (US$ Million) Table 112. China Pharmacokinetics Software Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Pharmacokinetics Software Revenue by Type (2021-2026) & (US$ Million) Table 114. Asia Pharmacokinetics Software Revenue by Type (2027-2032) & (US$ Million) Table 115. Asia Pharmacokinetics Software Revenue by Application (2021-2026) & (US$ Million) Table 116. Asia Pharmacokinetics Software Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Pharmacokinetics Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Pharmacokinetics Software Revenue by Region (US$ Million) & (2021-2026) Table 119. Asia Pharmacokinetics Software Revenue by Region (US$ Million) & (2027-2032) Table 120. SAMEA Pharmacokinetics Software Revenue by Type (2021-2026) & (US$ Million) Table 121. SAMEA Pharmacokinetics Software Revenue by Type (2027-2032) & (US$ Million) Table 122. SAMEA Pharmacokinetics Software Revenue by Application (2021-2026) & (US$ Million) Table 123. SAMEA Pharmacokinetics Software Revenue by Application (2027-2032) & (US$ Million) Table 124. SAMEA Pharmacokinetics Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. SAMEA Pharmacokinetics Software Revenue by Country (2021-2026) & (US$ Million) Table 126. SAMEA Pharmacokinetics Software Revenue by Country (US$ Million) & (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Pharmacokinetics Software Image Figure 2. Global Pharmacokinetics Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmacokinetics Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Compartmental Model Image Figure 5. Non-Compartmental Models Image Figure 6. Global Pharmacokinetics Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pharmacokinetics Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. Experimental Design Image Figure 9. Clinical Pharmacokinetics Image Figure 10. Other Image Figure 11. Global Pharmacokinetics Software Market Size (US$ Million) & (2021-2032) Figure 12. Global Pharmacokinetics Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pharmacokinetics Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Pharmacokinetics Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Pharmacokinetics Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pharmacokinetics Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pharmacokinetics Software Revenue Market Share by Type (2021-2032) Figure 19. Global Pharmacokinetics Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pharmacokinetics Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Pharmacokinetics Software Revenue Market Share by Application (2021-2032) Figure 22. North America Pharmacokinetics Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Pharmacokinetics Software Revenue Share by Type (2021-2032) Figure 24. North America Pharmacokinetics Software Revenue Share by Application (2021-2032) Figure 25. North America Pharmacokinetics Software Revenue Share by Country (2021-2032) Figure 26. United States Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Pharmacokinetics Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Pharmacokinetics Software Revenue Share by Type (2021-2032) Figure 31. Europe Pharmacokinetics Software Revenue Share by Application (2021-2032) Figure 32. Europe Pharmacokinetics Software Revenue Share by Country (2021-2032) Figure 33. Germany Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Pharmacokinetics Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Pharmacokinetics Software Revenue Share by Type (2021-2032) Figure 43. China Pharmacokinetics Software Revenue Share by Application (2021-2032) Figure 44. Asia Pharmacokinetics Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Pharmacokinetics Software Revenue Share by Type (2021-2032) Figure 46. Asia Pharmacokinetics Software Revenue Share by Application (2021-2032) Figure 47. Asia Pharmacokinetics Software Revenue Share by Region (2021-2032) Figure 48. Japan Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Pharmacokinetics Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Pharmacokinetics Software Revenue Share by Type (2021-2032) Figure 56. SAMEA Pharmacokinetics Software Revenue Share by Application (2021-2032) Figure 57. SAMEA Pharmacokinetics Software Revenue Share by Country (2021-2032) Figure 58. Brazil Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Pharmacokinetics Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Compartmental Model
  • Non-Compartmental Models
Applications
  • Experimental Design
  • Clinical Pharmacokinetics
  • Other
Companies covered
  • Certara
  • Simulations Plus
  • IntiQuan GmbH
  • Bayer
  • Genedata AG
  • Thermo Scientific
  • SGS
  • Pharmaron
  • Pumas-AI
  • PharmoGo
  • Chuangteng Technology
  • Medixi Biomedical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmacokinetics Software Market by Type
  3. 1.2.1 Global Pharmacokinetics Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Compartmental Model
  5. 1.2.3 Non-Compartmental Models
  6. 1.3 Pharmacokinetics Software Market by Application
  7. 1.3.1 Global Pharmacokinetics Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Experimental Design
  9. 1.3.3 Clinical Pharmacokinetics
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pharmacokinetics Software Market Dynamics
  1. 2.1 Pharmacokinetics Software Industry Trends
  2. 2.2 Pharmacokinetics Software Industry Drivers
  3. 2.3 Pharmacokinetics Software Industry Opportunities and Challenges
  4. 2.4 Pharmacokinetics Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmacokinetics Software Market Perspective (2021-2032)
  2. 3.2 Global Pharmacokinetics Software Growth Trends by Region
  3. 3.2.1 Global Pharmacokinetics Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmacokinetics Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmacokinetics Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmacokinetics Software Revenue by Players
  2. 4.1.1 Global Pharmacokinetics Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmacokinetics Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmacokinetics Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmacokinetics Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmacokinetics Software Key Players Headquarters & Area Served
  7. 4.4 Global Pharmacokinetics Software Players, Product Type & Application
  8. 4.5 Global Pharmacokinetics Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmacokinetics Software Market CR5 and HHI
  11. 4.6.3 2025 Pharmacokinetics Software Tier 1, Tier 2, and Tier 3
5 Pharmacokinetics Software Market Size by Type
  1. 5.1 Global Pharmacokinetics Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmacokinetics Software Revenue by Type (2021-2032)
  3. 5.3 Global Pharmacokinetics Software Revenue Market Share by Type (2021-2032)
6 Pharmacokinetics Software Market Size by Application
  1. 6.1 Global Pharmacokinetics Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmacokinetics Software Revenue by Application (2021-2032)
  3. 6.3 Global Pharmacokinetics Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Certara
  2. 7.1.1 Certara Company Information
  3. 7.1.2 Certara Business Overview
  4. 7.1.3 Certara Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Certara Pharmacokinetics Software Product Portfolio
  6. 7.1.5 Certara Recent Developments
  7. 7.2 Simulations Plus
  8. 7.2.1 Simulations Plus Company Information
  9. 7.2.2 Simulations Plus Business Overview
  10. 7.2.3 Simulations Plus Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Simulations Plus Pharmacokinetics Software Product Portfolio
  12. 7.2.5 Simulations Plus Recent Developments
  13. 7.3 IntiQuan GmbH
  14. 7.3.1 IntiQuan GmbH Company Information
  15. 7.3.2 IntiQuan GmbH Business Overview
  16. 7.3.3 IntiQuan GmbH Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 IntiQuan GmbH Pharmacokinetics Software Product Portfolio
  18. 7.3.5 IntiQuan GmbH Recent Developments
  19. 7.4 Bayer
  20. 7.4.1 Bayer Company Information
  21. 7.4.2 Bayer Business Overview
  22. 7.4.3 Bayer Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bayer Pharmacokinetics Software Product Portfolio
  24. 7.4.5 Bayer Recent Developments
  25. 7.5 Genedata AG
  26. 7.5.1 Genedata AG Company Information
  27. 7.5.2 Genedata AG Business Overview
  28. 7.5.3 Genedata AG Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Genedata AG Pharmacokinetics Software Product Portfolio
  30. 7.5.5 Genedata AG Recent Developments
  31. 7.6 Thermo Scientific
  32. 7.6.1 Thermo Scientific Company Information
  33. 7.6.2 Thermo Scientific Business Overview
  34. 7.6.3 Thermo Scientific Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Thermo Scientific Pharmacokinetics Software Product Portfolio
  36. 7.6.5 Thermo Scientific Recent Developments
  37. 7.7 SGS
  38. 7.7.1 SGS Company Information
  39. 7.7.2 SGS Business Overview
  40. 7.7.3 SGS Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 SGS Pharmacokinetics Software Product Portfolio
  42. 7.7.5 SGS Recent Developments
  43. 7.8 Pharmaron
  44. 7.8.1 Pharmaron Company Information
  45. 7.8.2 Pharmaron Business Overview
  46. 7.8.3 Pharmaron Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Pharmaron Pharmacokinetics Software Product Portfolio
  48. 7.8.5 Pharmaron Recent Developments
  49. 7.9 Pumas-AI
  50. 7.9.1 Pumas-AI Company Information
  51. 7.9.2 Pumas-AI Business Overview
  52. 7.9.3 Pumas-AI Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Pumas-AI Pharmacokinetics Software Product Portfolio
  54. 7.9.5 Pumas-AI Recent Developments
  55. 7.10 PharmoGo
  56. 7.10.1 PharmoGo Company Information
  57. 7.10.2 PharmoGo Business Overview
  58. 7.10.3 PharmoGo Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 PharmoGo Pharmacokinetics Software Product Portfolio
  60. 7.10.5 PharmoGo Recent Developments
  61. 7.11 Chuangteng Technology
  62. 7.11.1 Chuangteng Technology Company Information
  63. 7.11.2 Chuangteng Technology Business Overview
  64. 7.11.3 Chuangteng Technology Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Chuangteng Technology Pharmacokinetics Software Product Portfolio
  66. 7.11.5 Chuangteng Technology Recent Developments
  67. 7.12 Medixi Biomedical
  68. 7.12.1 Medixi Biomedical Company Information
  69. 7.12.2 Medixi Biomedical Business Overview
  70. 7.12.3 Medixi Biomedical Pharmacokinetics Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Medixi Biomedical Pharmacokinetics Software Product Portfolio
  72. 7.12.5 Medixi Biomedical Recent Developments
8 North America
  1. 8.1 North America Pharmacokinetics Software Revenue (2021-2032)
  2. 8.2 North America Pharmacokinetics Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmacokinetics Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmacokinetics Software Revenue by Type (2027-2032)
  5. 8.3 North America Pharmacokinetics Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmacokinetics Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmacokinetics Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmacokinetics Software Revenue by Application (2027-2032)
  9. 8.5 North America Pharmacokinetics Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmacokinetics Software Revenue by Country
  11. 8.6.1 North America Pharmacokinetics Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmacokinetics Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmacokinetics Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmacokinetics Software Revenue (2021-2032)
  2. 9.2 Europe Pharmacokinetics Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmacokinetics Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmacokinetics Software Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmacokinetics Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmacokinetics Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmacokinetics Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmacokinetics Software Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmacokinetics Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmacokinetics Software Revenue by Country
  11. 9.6.1 Europe Pharmacokinetics Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmacokinetics Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmacokinetics Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmacokinetics Software Revenue (2021-2032)
  2. 10.2 China Pharmacokinetics Software Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmacokinetics Software Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmacokinetics Software Revenue by Type (2027-2032)
  5. 10.3 China Pharmacokinetics Software Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmacokinetics Software Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmacokinetics Software Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmacokinetics Software Revenue by Application (2027-2032)
  9. 10.5 China Pharmacokinetics Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmacokinetics Software Revenue (2021-2032)
  2. 11.2 Asia Pharmacokinetics Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmacokinetics Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmacokinetics Software Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmacokinetics Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmacokinetics Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmacokinetics Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmacokinetics Software Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmacokinetics Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmacokinetics Software Revenue by Country
  11. 11.6.1 Asia Pharmacokinetics Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmacokinetics Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmacokinetics Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmacokinetics Software Revenue (2021-2032)
  2. 12.2 SAMEA Pharmacokinetics Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmacokinetics Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmacokinetics Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmacokinetics Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmacokinetics Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmacokinetics Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmacokinetics Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmacokinetics Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmacokinetics Software Revenue by Country
  11. 12.6.1 SAMEA Pharmacokinetics Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmacokinetics Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmacokinetics Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst